News & Announcements
-
IB & GE HealthCare Enter into Commercial Agreement
/**/ RNS Number : 8077J IQ-AI Limited 18 August 2023 18 August 2023 IQ-AI Ltd (“IQ-AI” or the “Company”) IB and GE HealthCare Enter into Commercial Agreement IB Neuro and IB Delta T1 to be embedded in GE HealthCare’s (GEHC) MR Smart Subscription Imaging Biometrics, LLC (IB), a wholly-owned subsidiary of
-
Half-year Report
/**/ RNS Number : 5460J IQ-AI Limited 17 August 2023 17 August 2023 IQ-AI Limited (the “Company” or the “Group”) Half Yearly Report for the Period Ended 30 June 2023 The Board of IQ-AI Ltd is pleased to announce the Company’s half yearly report for the period ended 30 June 2023. For further information,
-
Orphan Drug Designation for GaM in Pediatric GBM
/**/ RNS Number : 8411F IQ-AI Limited 13 July 2023 13 July 2023 IQ-AI Ltd (“IQ-AI” or the “Company”) Orphan Drug Designation for GaM in Pediatric GBM Imaging Biometrics, LLC (IB), a wholly-owned subsidiary of IQ-AI Ltd (LSE: IQAI, OTCQB: IQAIF), today announced the U.S. Food and Drug Administration (US FDA) has
-
Result of AGM
/**/ RNS Number : 3655A IQ-AI Limited 23 May 2023 IQ-AI Limited (“IQ-AI” or the “Company”) Result of AGM IQ-AI Limited announces that at the annual general meeting of the Company held earlier today, all resolutions were duly passed. The Directors of the Company accept responsibility for the contents of
-
AGM Statement
/**/ RNS Number : 2406A IQ-AI Limited 23 May 2023 IQ-AI Limited (“IQ-AI” or the “Company”) AGM Statement IQ-AI Limited is due to hold its AGM today. At the AGM, the Chairman will announce the following: • Over 200 more datasets have been received in collaboration with Phoenix Children’s Hospital.